Acorah Software Products - Accounts Production 15.0.600 false true 31 March 2023 1 April 2022 true 1 April 2023 31 March 2024 31 March 2024 05179241 S Macleod Barnes K Ladbon true iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 05179241 2023-03-31 05179241 2024-03-31 05179241 2023-04-01 2024-03-31 05179241 frs-core:CurrentFinancialInstruments 2024-03-31 05179241 frs-core:PlantMachinery 2024-03-31 05179241 frs-core:PlantMachinery 2023-04-01 2024-03-31 05179241 frs-core:PlantMachinery 2023-03-31 05179241 frs-core:ShareCapital 2024-03-31 05179241 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2023-03-31 05179241 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31 05179241 frs-bus:PrivateLimitedCompanyLtd 2023-04-01 2024-03-31 05179241 frs-bus:FullAccounts 2023-04-01 2024-03-31 05179241 frs-bus:SmallEntities 2023-04-01 2024-03-31 05179241 frs-bus:AuditExemptWithAccountantsReport 2023-04-01 2024-03-31 05179241 frs-bus:SmallCompaniesRegimeForAccounts 2023-04-01 2024-03-31 05179241 frs-bus:SmallCompaniesRegimeForDirectorsReport 2023-04-01 2024-03-31 05179241 frs-bus:OrdinaryShareClass1 2023-04-01 2024-03-31 05179241 frs-bus:OrdinaryShareClass1 2024-03-31 05179241 frs-bus:OrdinaryShareClass2 2023-04-01 2024-03-31 05179241 frs-bus:OrdinaryShareClass2 2024-03-31 05179241 frs-bus:OrdinaryShareClass3 2023-04-01 2024-03-31 05179241 frs-bus:OrdinaryShareClass3 2024-03-31 05179241 frs-bus:OrdinaryShareClass4 2023-04-01 2024-03-31 05179241 frs-bus:OrdinaryShareClass4 2024-03-31 05179241 frs-bus:OrdinaryShareClass5 2023-04-01 2024-03-31 05179241 frs-bus:OrdinaryShareClass5 2024-03-31 05179241 frs-bus:PreferenceShareClass1 2023-04-01 2024-03-31 05179241 frs-bus:PreferenceShareClass1 2024-03-31 05179241 frs-bus:PreferenceShareClass2 2023-04-01 2024-03-31 05179241 frs-bus:PreferenceShareClass2 2024-03-31 05179241 frs-bus:PreferenceShareClass3 2023-04-01 2024-03-31 05179241 frs-bus:PreferenceShareClass3 2024-03-31 05179241 frs-bus:PreferenceShareClass4 2023-04-01 2024-03-31 05179241 frs-bus:PreferenceShareClass4 2024-03-31 05179241 1 2023-04-01 2024-03-31 05179241 frs-bus:Director1 2023-04-01 2024-03-31 05179241 frs-bus:CompanySecretary1 2023-04-01 2024-03-31 05179241 frs-countries:EnglandWales 2023-04-01 2024-03-31 05179241 2022-03-31 05179241 2023-03-31 05179241 2022-04-01 2023-03-31 05179241 frs-core:CurrentFinancialInstruments 2023-03-31 05179241 frs-core:ShareCapital 2023-03-31 05179241 frs-core:RetainedEarningsAccumulatedLosses frs-core:PreviouslyStatedAmount 2022-03-31 05179241 frs-core:RetainedEarningsAccumulatedLosses 2023-03-31 05179241 frs-bus:OrdinaryShareClass1 2022-04-01 2023-03-31 05179241 frs-bus:OrdinaryShareClass2 2022-04-01 2023-03-31 05179241 frs-bus:OrdinaryShareClass3 2022-04-01 2023-03-31 05179241 frs-bus:OrdinaryShareClass4 2022-04-01 2023-03-31 05179241 frs-bus:OrdinaryShareClass5 2022-04-01 2023-03-31 05179241 frs-bus:PreferenceShareClass1 2022-04-01 2023-03-31 05179241 frs-bus:PreferenceShareClass2 2022-04-01 2023-03-31 05179241 frs-bus:PreferenceShareClass3 2022-04-01 2023-03-31 05179241 frs-bus:PreferenceShareClass4 2022-04-01 2023-03-31
Registered number: 05179241
Caledonia Medical Limited
Director's Report and
Unaudited Financial Statements
For The Year Ended 31 March 2024
Director's Report and Unaudited Financial Statements
Contents
Page
Company Information 1
Director's Report 2
Accountants' Report 3
Statement of Income and Retained Earnings 4
Balance Sheet 5—6
Notes to the Financial Statements 7—9
Page 1
Company Information
Director S Macleod Barnes
Secretary K Ladbon
Company Number 05179241
Registered Office Ground Floor Marlborough House
298 Regents Park Road
London
N3 2SZ
Accountants Exceed Accountants Limited
Ground Floor Marlborough House
298 Regents Park Road
London
N3 2SZ
Page 1
Page 2
Director's Report
The director presents his report and the financial statements for the year ended 31 March 2024.
Principal Activity
The company's principal activity continues to be that of medical services.
Directors
The director who held office during the year were as follows:
S Macleod Barnes
Small Company Rules
This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
On behalf of the board
S Macleod Barnes
Director
18/09/2024
Page 2
Page 3
Accountants' Report
In accordance with the engagement letter, and in order to assist you to fulfil your duties under the Companies Act 2006, we have compiled the financial statements of the company from the accounting records and information and explanations you have given to us.
This report is made to the directors in accordance with the terms of our engagement. Our work has been undertaken to prepare for approval by the directors the financial statements that we have been engaged to compile, to report to the directors that we have done so, and to state those matters that we have agreed to state to them in this report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's directors for our work or for this report.
You have acknowledged on the balance sheet as at period ended 31 March 2024 your duty to ensure that the company has kept proper accounting records and to prepare financial statements that give a true and fair view under the Companies Act 2006. You consider that the company is exempt from the statutory requirement for an audit for the year.
We have not been instructed to carry out an audit of the financial statements. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the financial statements.
Signed
18/09/2024
Exceed Accountants Limited
Ground Floor Marlborough House
298 Regents Park Road
London
N3 2SZ
Page 3
Page 4
Statement of Income and Retained Earnings
2024 2023
Notes £ £
TURNOVER 1,861,497 1,737,778
Cost of sales (1,017,154 ) (909,260 )
GROSS PROFIT 844,343 828,518
Administrative expenses (253,649 ) (169,679 )
OPERATING PROFIT 590,694 658,839
Amounts written off investments (20,000 ) -
Other interest receivable and similar income 464 -
PROFIT BEFORE TAXATION 571,158 658,839
Tax on Profit (149,071 ) (126,515 )
PROFIT AFTER TAXATION BEING PROFIT FOR THE FINANCIAL YEAR 422,087 532,324
RETAINED EARNINGS
As at 1 April 2023 388,919 194,595
Dividends paid (429,577) (338,000)
As at 31 March 2024 381,429 388,919
The notes on pages 7 to 9 form part of these financial statements.
Page 4
Page 5
Balance Sheet
2024 2023
Notes £ £ £ £
FIXED ASSETS
CURRENT ASSETS
Debtors 4 549,780 465,914
Cash at bank and in hand 162,391 270,546
712,171 736,460
Creditors: Amounts Falling Due Within One Year 5 (330,632 ) (347,431 )
NET CURRENT ASSETS (LIABILITIES) 381,539 389,029
TOTAL ASSETS LESS CURRENT LIABILITIES 381,539 389,029
NET ASSETS 381,539 389,029
CAPITAL AND RESERVES
Called up share capital 6 110 110
Profit and Loss Account 381,429 388,919
SHAREHOLDERS' FUNDS 381,539 389,029
Page 5
Page 6
For the year ending 31 March 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.
On behalf of the board
S Macleod Barnes
Director
18/09/2024
The notes on pages 7 to 9 form part of these financial statements.
Page 6
Page 7
Notes to the Financial Statements
1. Accounting Policies
1.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
1.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.
Rendering of services
Turnover from the rendering of services is recognised by reference to the stage of completion of the contract.
1.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:
Plant & Machinery 33% on cost
1.4. Foreign Currencies
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
1.5. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
1.6. Pensions
The company operates a defined pension contribution scheme. Contributions are charged to the profit and loss account as they become payable in accordance with the rules of the scheme.
2. Average Number of Employees
Average number of employees, including directors, during the year was as follows: 2 (2023: 2)
2 2
Page 7
Page 8
3. Tangible Assets
Plant & Machinery
£
Cost
As at 1 April 2023 2,360
As at 31 March 2024 2,360
Depreciation
As at 1 April 2023 2,360
As at 31 March 2024 2,360
Net Book Value
As at 31 March 2024 -
As at 1 April 2023 -
4. Debtors
2024 2023
£ £
Due within one year
Trade debtors 268,280 384,489
Other debtors 275,843 76,319
VAT 5,277 5,106
Other taxes and social security 380 -
549,780 465,914
5. Creditors: Amounts Falling Due Within One Year
2024 2023
£ £
Trade creditors 179,070 193,855
Corporation tax 149,146 126,515
Other taxes and social security - 37
Other creditors 2,416 6,185
Director's loan account - 20,839
330,632 347,431
Page 8
Page 9
6. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 110 110
Value Number 2024 2023
Allotted, called up and fully paid £ £ £
Ordinary Shares 1 100 100 100
Ordinary A shares 1 1 1 1
Ordinary B shares 1 1 1 1
Ordinary C shares 1 1 1 1
Ordinary D shares 1 1 1 1
Ordinary E shares 1 1 1 1
Ordinary F shares 1 1 1 1
Preference Shares 1 1 1 1
Preference A shares 1 1 1 1
Preference B shares 1 1 1 1
Preference C shares 1 1 1 1
110 110 110
7. Ultimate Controlling Party
The company's ultimate controlling party is the company director by virtue of his shareholding.
8. General Information
Caledonia Medical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 05179241 . The registered office is Ground Floor Marlborough House, 298 Regents Park Road, London, N3 2SZ.
Page 9